moxifloxacin has been researched along with ppi-0903 in 3 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (ppi-0903) | Trials (ppi-0903) | Recent Studies (post-2010) (ppi-0903) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 519 | 39 | 451 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajaksouzian, S; Biek, D; Critchley, IA; Good, CE; Jacobs, MR; Jones, RN; Sader, HS; Windau, AR | 1 |
| Jacobus, NV; McDermott, LA; Snydman, DR | 1 |
| Llorens, L; Rank, D; Rekeda, L; Riccobene, TA | 1 |
1 trial(s) available for moxifloxacin and ppi-0903
| Article | Year |
|---|---|
Evaluation of the effect of a supratherapeutic dose of intravenous ceftaroline fosamil on the corrected QT interval.
Topics: Adolescent; Adult; Aza Compounds; Ceftaroline; Cephalosporins; Cross-Over Studies; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Young Adult | 2013 |
2 other study(ies) available for moxifloxacin and ppi-0903
| Article | Year |
|---|---|
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; United States | 2010 |
In vitro activity of ceftaroline against a broad spectrum of recent clinical anaerobic isolates.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Anaerobic; Ceftaroline; Ceftriaxone; Cephalosporins; Clindamycin; Fluoroquinolones; Imipenem; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Quinolines; Tigecycline | 2011 |